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smaller. Therefore, the dose to the OARs will be wrongly estimated if 
the MIP scan is used for delineation. 
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Purpose/Objective: Two types of dosimetric effects due to intra-
fractional organ motion has been defined; A) the dose-'blurring' or 
'smearing' effect, where the dose delivered to a point in the patient is 
smeared by the motion of this point in the radiation beam, and B) the 
interplay effect, where the relative motion between the dynamic MLC 
leaves and the treatment region may lead to a more complicated 
dosimetric effect. The aim of this study was to investigate any 
potential breathing interplay effects during VMAT using 3D polymer 
gel measurements and compare this with the measurement 
uncertainty. 
Materials and Methods: To simulate tumour movement caused by 
respiratory motion, the gel phantoms were positioned on a 
programmable motion platform (Standard Imaging, Inc), which was set 
to carry out sinusoidal motion. Two different VMAT (RapidArc®, 
Varian Medical Systems) plans were delivered; a 6 MV small target 
plan and a 18MV larger target plan. Each delivery was carried out both 
to a stationary polymer gel phantom and to a gel phantom during 
motion with a peak-to-peak distance of 20 mm during a period of 4 s 
and 5 s, respectively. In order to evaluate the dosimetric impact of 
the interplay between the phantom motion and the dynamic 
treatment delivery, we defined the dosimetric interplay effect as the 
relative 3D absorbed dose difference between the volumes obtained 
from the VMAT measurement during phantom motion and the VMAT 
measurement to a stationary phantom convolved with the motion 
function of the moving platform. 
Results: The total dosimetric effect of motion was evaluated, i.e. the 
dose difference between the volume obtained from the measurement 
during phantom motion and the measurement to a stationary 
phantom. The isodose volume ≥ 90% was investigated. The mean value 
and standard deviation of the differences obtained from the 
measurements were (-3.7±2.6)% for the small target plan and (-
4.3±4.8)% for the larger target plan. Investigating the interplay effect, 
the relative dose difference between the measured VMAT delivery 
during phantom motion and the convolved stationary VMAT delivery 
resulted in (-1.2± 1.4)% and (0.9±2.3)% for the small and larger plan, 
respectively. The results were compared to the dose difference 
between two repeated stationary convolved gel measurement, which 
resulted in (0.06±0.5)% and (0.4±0.9)% for the small and larger plan 
respectively. Although the interplay effects were small compared to 
the smearing effect, the standard deviations were significantly 
(p<0.001) larger than the narrow distribution for repeated stationary 
measurement. 
Conclusions: The total dosimetric effect due to target motion and 
dynamic MLC motion during VMAT delivery resulted in an average of 
about 4% target dose reduction. Comparing with the convolved 
stationary measurement, which includes only the smoothing effect, 
the average difference was decreased to around 1%, and the 
remaining deviation was attributed to interplay effects.  
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Purpose/Objective: Repeated MR imaging during radiotherapy enables 
treatment adaptation based on soft tissue information. Sufficient 
contrast permits identification of the target and normal tissues and 
makes a plan adaptation for cervical cancer irradiation possible. In 
that context one limiting factor will be time-consuming manual plan 
generation. The aim is therefore to establish fast automated IMRT 
planning based on a class solution for offline (dedicated MR outside of 
the treatment room) or even online (MR-Linac) adaptation. 
Materials and Methods: For 10 cervical cancer patients 1 initial CT 
and MR as well as 4 weekly MRs were available. On those 50 T2-
weighted transversal MR scans OAR (bladder, rectum and small bowel) 
as well as target structures (primary, nodal CTV) were manually 
contoured by an experienced radiation oncologist. Assuming a plan 
adaptation concept PTVs with 4mm uniform margin were created. The 
weekly MRs with their respective structure sets were rigidly registered 
to the CT based on bony anatomy. Treatment plans were generated 
using 7 beams (6MV) equally distributed around the patient. For each 
angle beamlets were calculated for a projected area, which contained 
the PTVs plus a margin of 4mm. The dose calculation was performed 
with a GPU-based Monte Carlo code (GPUMCD) using the CT data. 
GPUMCD enables dose calculation in the absence (0T) and presence of 
a magnetic field (1.5T). The beamlet weights were determined by the 
fast inverse dose optimization (FIDO) using a class solution for the 
constraints of target (prescription dose of45Gy) and OAR structures. 
Dose constraints for the OAR were chosen to be very demanding and 
are beyond most criteria mentioned in current clinical studies (e.g. 
RTOG 0418 or INTERTECC study). Target coverage, OAR sparing and 
timing issues were analyzed. 
Results: 100 plans (1 initial and 4 weekly plans for 10 patients with 
and without a magnetic field) were generated and all fulfilled the 
ICRU criterion for targets, e.g. D95>42.75Gy. The dose distributions in 
the targets were very homogeneous with a mean D1cc of 48.2Gy. Only 
5 plans had a D40>40Gy for the bladder (see Fig. 1 - also for rectum 
and bowel values). For the rectum 30% of the plans had a D50>30Gy. 
This was mainly the case when the rectum was empty and closely 
attached to the primary target. In general the D50 for the rectum was 
not above 35Gy. For the small bowel 4 plans show a D50 above 30Gy. 
No significant difference between 0T and 1.5T plans could be 
identified. Assuming the use of one GPU per beam anautomated plan 
generation within 2 or 5 minutes (0 or 1.5T) could be shown. 
 
  
Conclusions: With the current setting automated plans were 
generated which mostly fulfilled planning criterion. In few cases with 
insufficient OAR sparing small adaptions of the weight factors for the 
planning constraints led to acceptable plans. Fast, automated plan 
generation for cervical cancer using a class solution is possible. 
Further research will focus on fast, automated contour propagation.  
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Purpose/Objective: To develop a marker based adaptation strategy, 
the fluence adaptation of Mohan et al.1, is combined with a non-MU 
preserving step taking into account tumor depth and heterogeneities. 
Materials and Methods: The adaptation has a geometric and a 
dosimetric step. The geometric step contains:  
· A rigid jaw translation using the average detected marker 
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· A thin plate spline deformation, adapting the original fluence0 into 
fluenceX. In contrast to Ref.1 marker positions are used instead of 
organ contours. 
· An adapted leaf motion, calculated in Eclipse (Varian Medical 
Systems, Palo Alto, CA). 
For the dosimetric step ray tracing5 is used to calculate the 
radiological path length d, from the source to each marker. Next, the 
tissue to phantom ratio, TPR(0.5,d), is calculated using a fixed 0.5cm 
field size. The TPRplanX / TPRplan0-median over the different markers 
rescales the number of monitor units of each beam. 
For validation a 5 beam sliding window IMRT plan is optimized for the 
TG119 prostate structures2. The phantom is extended with 4 markers 
and bony anatomy. The initial plan0 delivers 77Gy(2.2Gy/Fr). 
Fractions are simulated by applying translations and isotropic scaling 
using literature values (Table 1). The isotropic expansion is derived 
from the shrinkage factor, and is used to evaluate the robustness of 
our approach. 
 
 Type Magnitude Structures 
T1 Rigid translation3 
(Lat, Vrt, Lng) [mm] 
( -0.4, 2.5, -2.6) All 
T2 ( -4.7, 8.2, -8.0) 
T3 (-9.0, 14.9, -13.4) 
S1 Isotropic shrinkage4 Expansion factor = 0.9 Target + Markers
E1 Isotropic expansion4 Expansion factor = 1.1 
Table 1: Overview of the applied deformations. The type and 
magnitude are listed in column 2 and 3. Column 4 indicates on which 
structures the deformations are applied. 
 
Results: Results are compared to plan0 and our clinical standard: 
shifting of the phantom according to the detected marker positions, 
see Figure 1. 
The combination of the geometric and dosimetric adaptation results in 
an identical target coverage as was intended (planX = plan0). The 
geometric adaptation alone reduces target coverage compared to 
plan0 (upper left), similar as our clinical practice (upper row, dashed 
line (left) vs. solid gray line (right)). All translations have similar 
results. 
  Figure 1. The DVH and conformity results. DVHs of a transformation 
(T2 upper row), and target shrinkage (S1,E1 lower row) are depicted. 
 
For S1 and E1 a strongly improved conformity is observed for the 
adaptation compared to the clinical practice (Figure1). The 
adaptation ensures a stable, better CI95 compared to our clinical 
practice for all applied deformations, this indicates better OAR 
protection. 
Conclusions: Target coverage, conformity, and as consequence OAR 
protection is improved by the presented non-MU preserving 
adaptation. 
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Purpose/Objective: To analyse the accuracy of image-guidance using 
the cone-beam CT technology of the VERO SBRT system in stereotactic 
radiotherapy of lung tumors.  
Materials and Methods: So far 22 consecutive patients have been 
treated with stereotactic treatment using the VERO system (BrainLAB 
AG, Mitsubishi Heavy Industries). A free breathing CT scan and a 10-
phase respiration correlated 4D-CT to allow patient-specific motion 
assessment were acquired with a slice thickness of 2.5 mm. The Real-
time Position Management respiratory gating system (RPM, Varian) 
was used to generate the external breathing signal and to 
retrospectively correlate cine CT images with the breathing phases. 
Patients, positioned supine with an arm holder (Posirest, Civco), were 
trained to achieve a regular breathing with the aid of a wearable 
display showing the breathing cycle. The internal target volume (ITV) 
was obtained contouring the tumor on the reconstructed maximum 
intensity projection and the mean intensity projection CT images. The 
PTV was generated with a safety margin of 5 mm to account for setup 
uncertainties. Treatment plans, consisting of 1-3 non coplanar 
conformal dynamic arcs or multiple IMRT fields, were generated for 
the VERO system. Doses between 25 and 54 Gy were delivered to the 
isocenter in 3 to 5 fractions. Patients were setup according to 
Exactrac and target localization was achieved with a kV-CBCT. Due to 
the limited field of view, in most of the cases the vertebral spine was 
not visible for evaluation of the patient set-up. The clipbox for 
automatic soft-tissue registration of the CBCT and the planning CT 
was confined around the lesion. The radiation oncologist then 
performed a manual registration to adjust the position of the ITV and 
PTV to the motion-blurred tumor in all three planes in the CBCT. 
Translational and rotational target localization errors were corrected 
with the 5 degree-of-freedom robotic couch and the ring rotation. A 
verification CBCT was acquired after correction to evaluate residual 
errors. If residual error was greater than 2 mm in any direction, a 
second correction was made and another CBCT acquired. 
Results: In the table are shown the group mean, the systematic (Σ) 
and random (σ) component of the tumor localization errors and 
residual errors after correction, in terms of translations and rotations. 
Data were obtained from the analysis of 168 CBCTs. The mean 3D 
vector at initial set-up was 5.7±1.4 mm, while was significantly 
reduced to 1.4±0.6 mm after 6D automatic correction.  
 
Translations (mm) Rotations (°) 
LR  SI  AP  3D vector roll  pitch yaw 
Tumor localization Group mean 0.5 1.7 -3.4 5.7 0.6 0.0 0.1 
error Σ 1.2 3.2 1.9 1.4 0.7 1.0 1.0 
σ 1.7 2.3 1.9 1.9 0.8 0.9 1.4 
Residual error Group mean -0.1 0.0 0.0 1.4 -0.1 0.0 0.0 
Σ 0.5 0.7 0.6 0.6 0.3 0.2 0.3 
σ 0.5 1.0 1.0 1.0 0.4 0.4 0.3 
 
Conclusions: On-line CBCT image guidance and automatic 6D 
correction available on the VERO system allowed a very accurate 
tumor localization in lung stereotactic treatments. A post-treatment 
CBCT will be acquired in the next group of patients to assess the 
safety margins required to compensate for residual positional 
uncertainties and intra-fraction tumor displacement. 
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Purpose/Objective: Treatment planning and irradiation of lung cancer 
patients are often based on the mid-ventilation phase in order to 
minimize planning margins. The primary lung tumour and involved 
lymph node located in the mediastinum region can have different 
respiratory patterns. There can be a systematic baseline shift across 
the entire treatment course between the primary tumour and the 
lymph node as well as daily random baseline variations. It is desirable 
to correct for baseline shifts that occurs daily for the primary lung 
tumour but that might cause a discrepancy between the planned and 
delivered dose distribution to the lymph node. This study investigates 
the dose coverage of the lymph node when the entire dose 
distribution is shifted in accordance with baseline shift of the primary 
tumour. 
